Gandeeva Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Gandeeva Therapeutics, Inc. - overview
Established
2021
Location
Vancouver, BC, Canada
Primary Industry
Biotechnology
About
Founded in 2021 and based in Vancouver, Canada, Gandeeva Therapeutics, Inc. operates as a biotechnology company that develops novel therapeutics through the use of cryogenic electron microscopy (cryo-EM) and machine learning. In 2021, the company was founded by Sriram Subramaniam, a medical expert that revolutionised the cryo-EM, also known as cryo-electron microscopy, method in clinical usage. He also has contribution to the study of HIV-1, influenza, and related viruses for vaccine development, and in focused ion beam technologies for cell and tissue imaging.
Gandeeva develop pharmaceuticals via its AI-driven platforms -- SPOTLIGHT, HYPERFOCUS, CRYO-CADD -- all of which are engines that can help with drug develop process. SPOTLIGHT is the hit product that can visualise measure and capture protein-protein and protein-drug interactions to target disease-relevant proteins and influence their function.
Current Investors
Amgen Ventures, Lux Capital, Obvious
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.gandeeva.com
Verticals
Artificial Intelligence
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.